Comment on the Updated AASLD Practice Guidelines for the Diagnosis, Management, and Treatment of Hepatitis C: Treating Active Drug Users

被引：8
|
作者：
Swan, Tracy [1 ]
Curry, Jen [2 ]
机构：
[1] Treatment Act Grp, New York, NY USA
[2] Harm Reduct Coalit, Oakland, CA USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 01期
关键词：
VIRUS-INFECTION; OUTCOMES; THERAPY; MODEL;
D O I：
10.1002/hep.23077
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：323 / 324
页数：2
相关论文
共 50 条
  • [41] Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions
    Langness, Jacob A.
    Nguyen, Matthew
    Wieland, Amanda
    Everson, Gregory T.
    Kiser, Jennifer J.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (09) : 1618 - 1626
  • [42] Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use
    Wilkinson, M.
    Crawford, V.
    Tippet, A.
    Jolly, F.
    Turton, J.
    Sims, E.
    Hekker, M.
    Dalton, J.
    Marley, R.
    Foster, G. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (01) : 29 - 37
  • [43] Screening, Diagnosis, Treatment, and Management of Hepatitis C: A Novel, Comprehensive, Online Resource Center for Primary Care Providers and Specialists
    Lebovics, Edward
    Czobor, Klara
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (11): : E11 - E14
  • [44] Prevalence and risk factors for Hepatitis C viral infection amongst a cohort of Irish drug users attending a drug treatment centre for Agonist Opioid Treatment (AOT)
    Keegan, David
    Crowley, Des
    Laird, Eamon
    Van Hout, Marie Claire
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2017, 19 (01) : 45 - 54
  • [45] Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-upaEuro
    Peterson, D. E.
    Boers-Doets, C. B.
    Bensadoun, R. J.
    Herrstedt, J.
    ANNALS OF ONCOLOGY, 2015, 26 : V139 - V151
  • [46] Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations-Diagnosis and Management
    Shah, Monica
    Younossi, Zobair M.
    AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (05): : S86 - S96
  • [47] Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study
    Boglione, L.
    Pinna, S. Mornese
    De Nicolo, A.
    Cusato, J.
    Cariti, G.
    Di Perri, G.
    D'Avolio, A.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (10) : 850 - 857
  • [48] Hepatitis C treatment outcome in former or current intravenous drug users coinfected with HIV, with or without directly observed therapy
    Sarmento-Castro, R.
    Mendez, J.
    Horta, A.
    Goncalves, C.
    Vasconcelos, O.
    Seabra, J.
    Abreu, M.
    Goncalves, M. J.
    Santos, M. J.
    Tavares, A. P.
    INFECTIOUS DISEASES, 2021, 53 (01) : 9 - 18
  • [49] Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes
    Guadagnino, Vincenzo
    Trotta, Maria Paola
    Montesano, Franco
    Babudieri, Sergio
    Caroleo, Benedetto
    Armignacco, Orlando
    Carioti, Jessica
    Maio, Giuseppe
    Monarca, Roberto
    Antinori, Andrea
    ADDICTION, 2007, 102 (03) : 423 - 431
  • [50] CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults
    Hull, Mark
    Shafran, Stephen
    Tseng, Alice
    Giguere, Pierre
    Klein, Marina B.
    Cooper, Curtis
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2014, 25 (06): : 311 - 320
12345